Lista de obras -

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

artículo científico publicado en 2017

Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.

artículo científico publicado en 2018

Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.

artículo científico

Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients

artículo científico publicado en 2013

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.

artículo científico publicado en 2006

Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.

artículo científico publicado en 2009

Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis

artículo científico publicado en 2011

Curative treatment for severe sickle cell disease: allogeneic transplantation

artículo científico

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

artículo científico publicado en 2003

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study

artículo científico publicado en 2010

First report that prior ECMO therapy does not preclude hematopoietic cell transplantation

scientific article published on 01 May 2018

Hematopoietic stem cell transplantation for sickle cell disease: state of the science.

artículo científico publicado en 2014

Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2018

Long-term follow-up of children with fever of unknown origin.

artículo científico publicado en 2000

Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies ⬇️

artículo científico publicado el 1 de enero de 2012

New frontiers in pediatric Allo-SCT.

artículo científico publicado en 2014

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression

artículo científico publicado en 2018

Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

artículo científico publicado en 2018

Recent molecular and cellular advances in pediatric bone marrow transplantation.

artículo científico publicado en 2006

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

scientific article published on 11 July 2018

Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

scientific article published on 17 August 2017

Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience

artículo científico publicado en 2016

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-H

artículo científico publicado en 2014

Smoothing the crescent curve: sickle cell disease.

artículo científico publicado en 2014

Successful treatment of recurrent CNS disease post-bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis.

artículo científico publicado en 2016

The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuk

artículo científico publicado en 2018

The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients.

artículo científico publicado en 2013

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

artículo científico publicado en 2015

Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH

artículo científico publicado en 2011

Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric

artículo científico publicado en 2018

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial

artículo científico publicado en 2014

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

artículo científico publicado en 2016

Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis.

artículo científico publicado en 2017

Lista de obras de

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.

Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.

Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.

Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.

Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis

Curative treatment for severe sickle cell disease: allogeneic transplantation

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study

First report that prior ECMO therapy does not preclude hematopoietic cell transplantation

Hematopoietic stem cell transplantation for sickle cell disease: state of the science.

Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.

Long-term follow-up of children with fever of unknown origin.

Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies ⬇️

New frontiers in pediatric Allo-SCT.

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression

Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Recent molecular and cellular advances in pediatric bone marrow transplantation.

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-H

Smoothing the crescent curve: sickle cell disease.

Successful treatment of recurrent CNS disease post-bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis.

The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuk

The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients.

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH

Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis.